≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Iliotibial band syndrome

DOID EFO Endpoint Browser PheWeb

M13_ILIOTIBBAND

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M76.3
  • Hospital discharge: ICD-9 — 7265B|7266G
  • Cause of death: ICD-10 — M76.3
  • Cause of death: ICD-9 — 7265B|7266G

2 out of 7 registries used, show all original rules.

430

4. Check minimum number of events

None

430

5. Include endpoints

None

430

6. Filter based on genotype QC (FinnGen only)

430

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M76
Name in latin
Syndroma tractus iliotibialis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2417 1492 918
Only index persons 2369 1469 900
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.03
Only index persons 0.05 0.05 0.03
Median age at first event (years)
Whole population 43.28 50.72 31.26
Only index persons 43.28 50.64 31.26

-FinnGen-

Key figures

All Female Male
Number of individuals 430 322 108
Unadjusted period prevalence (%) 0.09 0.11 0.05
Median age at first event (years) 50.97 52.71 45.79

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
398
Matched controls
3980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.3
ICD-10 Finland
Iliotibial band syndrome
16384.0
323.0
376
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
38.5
65.4
83
27
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
31.2
52.5
70
27
M54.5
ICD-10 Finland
Low back pain
5.4
46.2
173
493
M48.0
ICD-10 Finland
Spinal stenosis
60.9
45.9
53
10
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
47.9
44.8
54
13
N03AX16
ATC
pregabalin; oral
6.2
43.5
136
308
M54.4
ICD-10 Finland
Lumbago with sciatica
8.9
43.1
99
143
M01AH05
ATC
etoricoxib; oral
4.8
42.7
306
1638
M70.6
ICD-10 Finland
Trochanteric bursitis
7.2
38.0
100
176
N03AX12
ATC
gabapentin; oral
7.6
34.3
86
139
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
191.3
34.3
35
*
M25.5
ICD-10 Finland
Pain in joint
4.1
34.1
173
626
M79.6
ICD-10 Finland
Pain in limb
3.8
32.0
191
784
N02AX02
ATC
tramadol; systemic, rectal
3.7
31.9
198
838
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
313.7
29.2
29
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.1
27.1
124
394
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
150.2
27.0
28
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
47.9
25.9
31
7
M01AB05
ATC
diclofenac; systemic, rectal
3.4
25.7
304
1951
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
25.4
213
1074
M53.1
ICD-10 Finland
Cervicobrachial syndrome
5.7
24.2
74
153
M03BX02
ATC
tizanidine; oral
3.1
23.8
287
1812
M03BC01
ATC
orphenadrine (citrate); systemic
3.5
22.7
128
475
M54.3
ICD-10 Finland
Sciatica
15.7
22.1
36
25
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
10.1
21.4
43
47
M76.0
ICD-10 Finland
Gluteal tendinitis
17.3
20.5
32
20
7266G
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[SDR TRACTUS ILIOTIBIALE]
+∞
20.0
19
*
M47.9
ICD-10 Finland
Spondylosis, unspecified
110.6
19.8
21
*
M47.82
ICD-10 Finland
Other spondylosis, cervical region
19.4
19.4
29
16
N06AX21
ATC
duloxetine; oral
5.4
19.3
61
130
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
36.3
19.1
24
7
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
10.6
19.1
37
38
M54.6
ICD-10 Finland
Pain in thoracic spine
7.2
18.3
45
69
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.8
18.2
47
77
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
17.6
18.1
28
17
M54.1
ICD-10 Finland
Radiculopathy
24.1
18.0
25
11
L86
ICPC
Back syndrome with radiating pain
9.0
17.9
38
46
M54.9
ICD-10 Finland
Dorsalgia, unspecified
6.0
17.3
49
91
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.3
17.1
67
178
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
27.0
17.1
23
9
M79.1
ICD-10 Finland
Myalgia
4.0
17.0
74
217
NFM10
NOMESCO Finland
Fasciotomy of thigh
+∞
16.8
16
*
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
16.8
16
*
S33.6
ICD-10 Finland
Sprain and strain of sacroiliac joint
+∞
16.8
16
*
L03
ICPC
Low back symptom/complaint
3.1
16.7
104
404
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
12.9
16.6
29
24
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
16.5
155
777
M02AA07
ATC
piroxicam; topical
2.6
16.3
163
847
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.5
16.1
60
152
A02BC03
ATC
lansoprazole; oral
2.7
16.0
130
597
L13
ICPC
Hip symptom/complaint
3.5
15.9
83
282
M01AC06
ATC
meloxicam; systemic, rectal
2.5
15.9
169
902
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
4.3
15.8
62
165
M01AH01
ATC
celecoxib; oral (coxibs)
3.3
15.5
85
300
N02AJ06
ATC
codeine and paracetamol; systemic
2.5
15.0
159
839
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
+∞
14.7
14
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.0
14.4
92
360
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.8
14.3
49
114
N02BE01
ATC
paracetamol; systemic, rectal
2.9
14.0
345
2759
M23.8
ICD-10 Finland
Other internal derangements of knee
7.0
13.9
34
52
L15
ICPC
Knee symptom/complaint
2.8
13.8
100
422
Z3226
NOMESCO Finland
Physiotherapist
3.0
13.6
86
331
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
5.5
13.5
40
79
M01AX05
ATC
glucosamine; oral
3.0
13.3
87
344
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
15.8
13.2
21
14
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
12.9
119
574
M53.0
ICD-10 Finland
Cervicocranial syndrome
4.6
12.9
46
111
M22.4
ICD-10 Finland
Chondromalacia patellae
7.1
12.8
31
47
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
12.6
12
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.6
12.5
58
178
A02BC02
ATC
pantoprazole; systemic
2.2
12.3
252
1761
G44.2
ICD-10 Finland
Tension-type headache
3.2
12.2
68
240
R03AC02
ATC
salbutamol; inhalant
2.1
11.9
213
1401
9476
FHL
Splitting of fascia or aponeurosis
31.1
11.7
15
5
M43.1
ICD-10 Finland
Spondylolisthesis
23.7
11.7
16
7
M01AE02
ATC
naproxen; oral, rectal
2.1
11.7
237
1636
M01AH02
ATC
rofecoxib; oral
3.5
11.5
55
174
J01AA02
ATC
doxycycline; systemic
2.3
11.4
314
2461
ZXA00
NOMESCO Finland
Right side
2.4
11.2
112
560
M54.2
ICD-10 Finland
Cervicalgia
5.4
11.2
33
65
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
3.8
11.1
47
134
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.5
11.1
104
501
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
5.9
11.0
30
54
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
18.5
10.8
16
9
N02AA05
ATC
oxycodone; systemic
3.4
10.8
53
171
A02BC05
ATC
esomeprazole; systemic
2.1
10.7
163
983
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
61.7
10.7
12
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
10.3
81
353
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
10.1
39
102
M03BC51
ATC
orphenadrine, combinations; systemic
2.2
10.1
127
703
M01AX17
ATC
nimesulide; oral
2.4
10.1
101
503
R06.0
ICD-10 Finland
Dyspnoea
2.5
10.0
91
429
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.0
9.9
58
212
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
8.1
9.7
21
27
R51.80
ICD-10 Finland
Headache
2.8
9.7
67
272
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
6.3
9.7
25
42
J01DB01
ATC
cefalexin; oral
2.2
9.7
328
2690
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
4.3
9.6
35
87
H02AB06
ATC
prednisolone; systemic
2.0
9.6
175
1122
SPAT1153
SPAT
Removal of sutures
2.1
9.5
123
687
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
9.3
107
566
J01FA10
ATC
azithromycin; systemic
1.9
9.3
246
1808
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.9
9.2
37
101
S80.0
ICD-10 Finland
Contusion of knee
3.7
9.2
39
112
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
8.6
9.2
19
23
M01AE01
ATC
ibuprofen; systemic, rectal
2.7
9.1
363
3154
ZXA05
NOMESCO Finland
Left side
2.3
9.1
100
516
N06AA09
ATC
amitriptyline; systemic
3.6
9.0
40
119
XQ800
NOMESCO Finland
Prick test
3.4
9.0
43
136
M54.8
ICD-10 Finland
Other dorsalgia
7.1
9.0
21
31
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
7.9
8.7
19
25
XA402
NOMESCO Finland
ENMG
11.9
8.6
15
13
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
8.4
152
960
M02AA10
ATC
ketoprofen; topical
2.6
8.4
65
280
RF210
NOMESCO Finland
NA
6.5
8.4
21
34
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
8.4
8
*
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
8.4
8
*
R42
ICD-10 Finland
Dizziness and giddiness
2.3
8.3
81
393
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
8.3
95
497
AA1AD
NOMESCO Finland
CT of head and brain
2.3
8.3
83
410
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
8.2
95
503
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.0
8.1
46
164
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
8.1
88
451
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
8.1
94
498
L01
ICPC
Neck symptom/complaint
2.7
8.1
55
222
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
5.6
8.0
22
41
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
7.9
217
1577
R01AD12
ATC
fluticasone furoate; nasal
1.9
7.8
130
793
R01BA52
ATC
pseudoephedrine, combinations; oral
1.9
7.7
135
838
J01FA15
ATC
telithromycin; oral
2.8
7.7
48
183
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
7.6
176
1201
NF1AA
NOMESCO Finland
Hip X-ray examination
3.6
7.6
33
97
A02BC01
ATC
omeprazole; systemic
2.1
7.6
98
541
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.2
7.5
27
67
S18
ICPC
Laceration/cut
1.9
7.5
148
956
M70.7
ICD-10 Finland
Other bursitis of hip
7.9
7.5
16
21
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
13.7
7.4
12
9
L08
ICPC
Shoulder symptom/complaint
2.2
7.4
76
379
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.3
7.4
36
116
J01FA06
ATC
roxithromycin; oral
1.8
7.4
163
1094
R5599
NOMESCO Finland
Other rehabilitation service
8.6
7.4
15
18
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
7.4
53
220
M35.7
ICD-10 Finland
Hypermobility syndrome
9.6
7.3
14
15
00000
ICD-8 Finland
NA
9.6
7.3
14
15
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
9.6
7.3
14
15
M79.7
ICD-10 Finland
Fibromyalgia
6.4
7.3
18
29
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
2.8
7.3
46
176
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
7.3
278
2223
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
16.1
7.3
11
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
7.2
140
898
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
7.2
102
583
R4110
NOMESCO Finland
Physiotherapy
2.0
7.2
100
565
Z2221
NOMESCO Finland
Medical doctor
1.9
7.0
115
691
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
3.6
7.0
30
88
R03AC03
ATC
terbutaline; inhalant
2.4
7.0
62
289
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
6.9
135
864
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.3
6.9
34
111
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.6
6.9
50
207
Z3231
NOMESCO Finland
Registered nurse
2.0
6.9
100
576
R06AE07
ATC
cetirizine; oral
1.8
6.9
175
1222
J02AC01
ATC
fluconazole; systemic
1.8
6.9
175
1222
R07.3
ICD-10 Finland
Other chest pain
3.2
6.8
35
118
M24.8
ICD-10 Finland
Other specific joint derangements, not elsewhere classified
40.8
6.8
8
*
J01CA04
ATC
amoxicillin; systemic
1.9
6.7
319
2700
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
5.7
6.7
18
33
ZXE00
NOMESCO Finland
One hour or less
1.8
6.6
149
995
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
6.6
134
867
S06.0
ICD-10 Finland
Concussion
2.7
6.6
43
169
R52.9
ICD-10 Finland
Pain, unspecified
3.0
6.6
37
131
R53
ICD-10 Finland
Malaise and fatigue
2.2
6.5
72
370
N06AX11
ATC
mirtazapine; oral
1.9
6.5
117
727
G57.1
ICD-10 Finland
Meralgia paraesthetica
14.6
6.4
10
7
R01AD09
ATC
mometasone; nasal
1.7
6.4
176
1248
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.3
6.4
18
35
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
3.1
6.4
34
118
UJF32
NOMESCO Finland
Coloscopy
2.0
6.3
87
490
M50.3
ICD-10 Finland
Other cervical disc degeneration
18.4
6.3
9
5
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
+∞
6.3
6
*
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
6.3
6
*
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
+∞
6.3
6
*
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
27.1
6.2
8
*
M01AX01
ATC
nabumetone; oral
4.5
6.1
20
46
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
5.3
6.1
17
33
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.7
6.1
40
159
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
10.2
6.1
11
11
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.5
6.1
46
198
R05FA02
ATC
opium derivatives and expectorants; systemic
1.7
6.0
162
1137
B01AB05
ATC
enoxaparin; parenteral
1.8
6.0
112
702

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
123
550
2.73
18.17
1.3
1.2
u/ml
4.0
12.4
1.70
46
221
(3013707) Erythrocyte sedimentation rate by Westergren method
330
2492
2.39
13.27
4.3
3.5
mm/h
9.3
10.7
1.56
314
2295
(3037522) Nuclear Ab [Titer] in Serum
96
445
2.49
12.74
1.3
1.4
titre
534.1
557.1
0.06
17
95
(3037467) Urinalysis macro (dipstick) panel - Urine
297
2240
2.05
10.62
4.8
3.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
326
2564
2.12
10.13
7.0
6.9
u/l
76.5
77.2
0.11
308
2410
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
215
1504
1.86
9.04
3.7
3.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
348
2.32
8.92
2.0
2.8
umol/l
5.1
7.6
1.23
67
299
(3024561) Albumin [Mass/volume] in Serum or Plasma
188
1265
1.86
8.91
4.0
4.3
g/l
36.5
36.3
0.20
176
1184
(3011397) Hemoglobin [Presence] in Urine by Test strip
115
667
1.99
8.47
4.3
2.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
240
1764
1.82
8.35
5.6
4.0
mmol/l
6.2
6.6
4.22
223
1629
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
400
3512
2.99
8.35
15.1
10.5
mg/l
17.8
22.3
2.25
312
2660
(3000475) Leukocytes [#/volume] in Synovial fluid
22
55
4.16
8.17
2.2
1.6
e6/l
4821.3
16985.9
0.68
17
43
(4010399)
47
192
2.63
7.97
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
77
395
2.16
7.84
2.1
2.2
ug/g
95.9
121.1
0.34
59
302
(3035350) Ketones [Presence] in Urine by Test strip
217
1567
1.78
7.84
4.1
3.0
estimate
0.0
0.0
0.00
35
298
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
104
597
1.98
7.82
1.4
1.2
iu/ml
11.9
31.5
4.63
34
205
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
454
2.06
7.45
3.7
2.5
e6/l
1.0
1.1
0.10
55
252
(3013650) Neutrophils [#/volume] in Blood by Automated count
251
1918
1.74
7.21
7.3
9.5
e9/l
3.9
3.9
0.03
220
1675
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
223
1649
1.73
7.20
5.4
6.3
umol/l
10.7
10.8
0.03
212
1588
(3044889) 12 lead EKG panel
294
2357
1.78
7.06
4.2
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
80
436
2.03
6.91
1.4
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
171
1185
1.74
6.89
2.0
1.8
pmol/l
103.7
97.8
0.85
69
585
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
342
2.14
6.88
8.6
4.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
155
1048
1.75
6.80
4.5
2.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
216
1601
1.70
6.78
5.5
4.3
estimate
0.0
0.0
0.50
36
300
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
333
2787
1.86
6.74
5.0
4.0
pmol/l
14.6
14.6
0.07
306
2563
(36304419) Bacteria [Presence] in Urine
123
779
1.81
6.73
4.1
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
216
1609
1.69
6.59
4.2
3.0
estimate
0.0
0.0
0.50
35
289
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
44
192
2.44
6.52
2.1
2.2
ug/l
5.6
7.0
0.20
38
175
(40761535) Cells panel - Urine sediment
45
199
2.41
6.48
3.8
2.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
218
1633
1.68
6.47
6.0
5.6
e9/l
0.0
0.0
0.04
196
1416
(3016502) Oxygen saturation in Arterial blood
50
233
2.30
6.40
7.4
7.2
%
96.4
96.0
0.34
50
227
(3001604) Monocytes [#/volume] in Blood
217
1628
1.67
6.37
6.0
5.6
e9/l
0.5
0.5
0.28
195
1407
(3013115) Eosinophils [#/volume] in Blood
223
1685
1.67
6.37
6.1
6.0
e9/l
0.2
0.2
0.25
205
1486
(3030467) Casts [#/volume] in Urine by Automated count
122
788
1.77
6.19
4.3
2.6
e6/l
0.3
0.4
0.96
99
581
(3014051) Protein [Presence] in Urine by Test strip
19
53
3.70
6.10
2.0
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
122
792
1.75
6.06
1.4
1.3
u/ml
1.1
1.7
0.48
37
215
(40768804) Tissue Pathology biopsy report
194
1441
1.63
5.74
2.3
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
49
238
2.19
5.69
1.6
2.4
ml/min/173m2
68.4
68.9
0.04
18
98
(3044941) Cell count panel - Synovial fluid
15
37
4.16
5.67
2.2
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
150
1047
1.66
5.65
5.2
3.2
e6/l
54.8
132.9
1.07
109
706
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
109
698
1.75
5.64
1.7
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
87
522
1.84
5.59
2.4
2.6
mmol/l
2.4
2.4
0.39
74
463
(3003396) Base excess in Arterial blood by calculation
53
268
2.12
5.56
7.4
6.6
mmol/l
1.1
1.1
0.04
43
217
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
42
194
2.29
5.49
1.1
1.3
—
41.8
—
0
13
(3019198) Lymphocytes [#/volume] in Blood
218
1679
1.61
5.48
6.1
5.5
e9/l
1.8
2.0
0.84
203
1488
(3045414) Leukocytes [Presence] in Urine
32
131
2.56
5.43
2.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
132
900
1.67
5.40
4.0
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
75
434
1.88
5.39
4.0
2.6
e6/l
2.1
3.2
0.77
47
233
(3000850) Epithelial cells [#/volume] in Urine
95
592
1.78
5.37
3.0
2.3
e6/l
5.9
6.2
0.11
87
515
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
507
1.82
5.28
4.8
3.1
ng/l
58.2
400.3
1.66
59
343
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
293
2438
1.63
5.23
3.4
2.8
u/l
48.9
44.6
0.30
276
2300
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
107
695
1.72
5.22
1.7
1.6
mg/l
0.8
1.0
1.33
87
528
(40761511) CBC panel - Blood by Automated count
408
3755
2.69
5.21
13.2
10.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
138
962
1.64
5.15
2.6
2.1
u/l
52.9
57.8
0.90
129
896
(3019150) Specific gravity of Urine by Refractometry
100
640
1.73
5.14
5.1
3.2
kg/l
1.0
1.0
—
6
95
(3026493) Urate [Moles/volume] in Serum or Plasma
116
778
1.67
5.01
2.1
2.5
umol/l
3537.7
5581.7
0.25
95
694
(3002582) Erythrocytes [#/volume] in Urine
127
872
1.65
5.01
4.6
2.8
e6/l
28.9
152.4
0.94
101
660
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
196
1496
1.57
4.96
6.3
6.0
mmol/l
1.2
1.2
0.55
170
1257
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
178
1334
1.57
4.85
6.2
5.0
mmol/l
1.2
1.2
1.77
162
1214
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
21
73
2.97
4.83
1.0
1.2
—
7.3
—
0
10
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
293
2463
1.60
4.77
3.6
3.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
33
146
2.37
4.77
8.6
7.8
%
1.5
1.3
0.39
33
146
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
187
2.19
4.68
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
32
141
2.37
4.67
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
148
1071
1.58
4.65
2.7
3.4
mmol/l
2.4
2.4
0.10
129
947
(3021788) Differential panel - Synovial fluid
15
43
3.58
4.65
2.3
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
44
224
2.07
4.55
8.0
7.3
g/l
116.0
121.4
1.06
44
218
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
155
1146
1.55
4.39
3.3
3.2
u/l
28.5
30.0
0.54
149
1102
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
368
3304
1.79
4.36
6.1
4.6
mu/l
1.8
2.2
0.73
351
3039
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
32
146
2.29
4.33
9.0
7.8
%
0.6
0.7
1.05
32
146
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
146
1069
1.55
4.30
4.3
3.0
ng/l
59.6
79.4
0.14
86
674
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
58
3.01
4.05
2.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
371
3359
1.76
4.00
16.5
11.7
%
39.9
40.1
0.16
291
2591
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
125
2.33
3.99
8.9
8.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
190
1491
1.49
3.97
3.2
2.6
ug/l
90.6
104.8
0.66
179
1376
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
410
3840
2.46
3.97
11.2
8.9
u/l
26.8
25.6
0.85
404
3704
(4094501)
22
88
2.58
3.94
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
101
697
1.59
3.80
2.0
2.0
mg/l
2.5
3.1
3.28
93
589
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
66
410
1.72
3.73
2.0
1.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
23
98
2.42
3.64
1.0
1.2
—
2.9
—
0
9
(3019060) Gas panel - Arterial blood
30
144
2.16
3.63
4.3
3.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
188
1496
1.46
3.56
6.0
5.7
%
0.7
0.7
0.07
175
1387
(3026782) Osmolality of Urine
86
582
1.60
3.49
3.1
2.3
mosm/kgh2o
533.9
561.3
0.60
80
501
(3007164) IgA [Mass/volume] in Serum or Plasma
98
685
1.56
3.47
1.5
1.5
g/l
2.5
2.3
0.35
53
432
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
285
1.81
3.47
2.7
2.0
u/l
28.1
41.0
1.29
44
250
(3006504) Eosinophils/100 leukocytes in Blood
193
1551
1.44
3.43
5.9
5.6
%
2.8
2.8
0.12
180
1437
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
160
1242
1.46
3.41
4.5
3.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
156
2.06
3.34
2.5
2.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
193
1557
1.43
3.33
6.2
5.8
%
8.3
8.4
0.16
179
1458
(3007853) Bacteria identified in Skin by Aerobe culture
51
304
1.77
3.33
1.7
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
149
1147
1.46
3.30
9.1
6.7
inr
1.3
1.2
0.50
37
369
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
43
3.09
3.27
2.0
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
94
660
1.54
3.25
1.6
1.4
nmol/l
22.5
21.6
0.24
80
549
(3019550) Sodium [Moles/volume] in Serum or Plasma
387
3594
1.77
3.18
17.8
11.8
mmol/l
139.6
139.8
0.70
381
3480
(3007461) Platelets [#/volume] in Blood
421
4055
2.83
3.16
22.4
16.2
e9/l
251.0
255.1
0.70
410
3944
(3023103) Potassium [Moles/volume] in Serum or Plasma
388
3609
1.77
3.13
17.9
11.9
mmol/l
3.9
3.9
0.01
381
3487
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
375
1.66
3.07
1.8
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
194
1584
1.41
3.06
6.0
5.5
%
56.6
56.6
0.02
180
1487
(3010813) Leukocytes [#/volume] in Blood
421
4060
2.76
3.03
22.5
16.3
e9/l
6.3
6.5
0.87
415
3936
(3026361) Erythrocytes [#/volume] in Blood
421
4059
2.78
3.03
22.5
16.2
e12/l
4.5
4.5
1.86
416
3939
(3018418) pH of Serum or Plasma
118
881
1.47
3.02
3.9
3.6
ph
7.4
7.4
0.08
19
169
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
94
2.30
3.01
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
215
1.84
2.95
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
129
2.08
2.92
1.7
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
33
179
1.91
2.91
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
354
3235
1.53
2.89
5.5
5.0
mmol/mol
37.7
39.1
3.28
334
3001
(42529406) Shigella sp [Presence] in Stool by Culture
21
96
2.25
2.88
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
113
845
1.46
2.86
4.3
6.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
100
730
1.48
2.86
2.7
3.0
ng/l
1051.8
940.6
0.09
91
609
(3002030) Lymphocytes/100 leukocytes in Blood
195
1608
1.39
2.84
6.1
5.7
%
28.6
28.8
0.08
183
1498
(3029937) Albumin [Presence] in Urine by Test strip
109
812
1.46
2.81
4.9
3.1
estimate
0.0
0.0
0.80
34
298
(3000330) Specific gravity of Urine by Test strip
28
146
1.98
2.77
3.1
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
133
1031
1.42
2.76
2.5
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
97
711
1.47
2.71
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
56
366
1.61
2.63
1.8
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
369
3424
1.55
2.58
4.7
4.0
mmol/l
5.7
5.8
2.10
353
3139
(3002385) Erythrocyte distribution width [Ratio]
334
3040
1.44
2.56
18.3
13.5
%
13.6
13.6
0.04
329
2976
(3000991) Gas panel - Venous blood
35
204
1.78
2.50
11.5
6.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
26
3.51
2.49
1.3
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
39
2.87
2.49
1.5
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
55
365
1.58
2.43
2.8
2.1
%
22.6
23.7
0.23
47
322
(40760892) CBC W Ordered Manual Differential panel - Blood
102
775
1.41
2.34
4.8
4.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
382
3593
1.57
2.27
4.6
4.0
mmol/l
4.8
4.8
0.39
362
3343
(3000494) Fungus identified in Specimen by Culture
55
372
1.55
2.25
1.5
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
28
159
1.81
2.19
3.0
2.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
164
1358
1.34
2.19
2.2
2.2
nmol/l
77.9
76.1
0.38
151
1237
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
364
3397
1.47
2.17
13.3
10.1
ml/min/173m2
85.0
83.7
0.65
293
2769
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
102
2.01
2.14
1.3
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
386
3648
1.57
2.13
5.2
4.4
mmol/l
2.9
2.9
0.26
366
3373
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
100
770
1.39
2.11
2.4
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
56
386
1.52
2.11
1.7
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
369
3457
1.48
2.11
3.9
3.6
mmol/l
1.2
1.3
0.28
347
3184
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
25
3.24
2.10
1.3
1.7
nmol/l
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
10
5.04
2.07
1.0
1.0
iu/ml
281.0
223.3
—
5
10
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
71
521
1.43
1.97
1.6
1.6
—
—
—
0
0
(4062490)
8
27
3.00
1.94
1.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
16
3.79
1.94
3.8
4.1
nmol/l
110.3
176.3
—
6
16
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
92
2.00
1.93
2.4
1.7
g/l
3.2
3.7
1.52
13
69
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
92
2.00
1.93
2.4
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
92
2.00
1.93
2.4
1.7
g/l
6.4
7.2
1.19
13
73
(3008898) HLA-B27 [Presence]
22
121
1.86
1.92
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
83
632
1.39
1.87
1.9
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
30
184
1.68
1.84
2.3
1.8
g/l
1.6
1.4
0.15
25
173
(3042936) Bacteria identified in Isolate by Culture
58
415
1.46
1.84
2.3
1.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
18
94
1.95
1.83
1.1
1.7
g/l
1.1
1.2
0.67
18
88
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
378
3580
1.46
1.81
4.6
4.0
mmol/l
1.5
1.5
0.27
356
3311
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
23
3.08
1.80
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
374
1.48
1.80
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
41
2.47
1.76
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
437
1.43
1.74
2.0
1.9
%
1.5
1.4
0.46
48
394
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
126
1.79
1.71
1.2
1.3
miu/ml
298.9
258.7
0.19
14
62
(3022621) pH of Urine by Test strip
30
188
1.64
1.71
3.4
2.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
55
2.22
1.69
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
55
2.22
1.69
1.1
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
128
1057
1.30
1.68
5.3
5.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
279
1.52
1.67
1.3
1.2
iu/ml
148.5
144.9
0.02
11
126
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40
271
1.52
1.66
1.8
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
25
2.83
1.65
1.4
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
25
2.83
1.65
1.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
64
482
1.39
1.55
1.5
1.6
nmol/l
1122.4
1117.7
0.02
48
350
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
93
1.86
1.54
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
117
1.74
1.47
1.4
2.2
u/l
407.7
2223.1
—
7
47
(3049717) Cytology report of Urine Cyto stain
17
95
1.82
1.45
1.9
2.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
103
1.78
1.43
4.1
4.5
%
1.6
1.5
0.10
18
97
(44790048)
7
29
2.44
1.39
1.3
1.8
—
—
—
0
0
(44790047)
7
29
2.44
1.39
1.3
1.8
—
—
—
0
0
(44806118)
7
29
2.44
1.39
1.3
1.8
—
—
—
0
0
(44790049)
7
29
2.44
1.39
1.3
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
175
1.58
1.38
1.5
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
111
922
1.27
1.37
2.5
3.2
mmol/l
7.6
7.7
0.13
90
789
(3023419) Bacteria identified in Sputum by Culture
6
23
2.63
1.37
1.7
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
103
848
1.28
1.37
2.6
3.3
mg/l
13.8
290.5
1.31
52
530
(3034770) Mitochondria Ab [Titer] in Serum
17
97
1.78
1.37
1.4
1.2
—
1400.0
—
0
5
(3024928) Oxygen saturation in Venous blood
10
47
2.15
1.34
10.8
3.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
42
2.17
1.34
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
35
2.31
1.27
1.5
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
22
139
1.61
1.26
1.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
4.5
4.8
nmol/l
8.8
216.3
—
6
25
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
101
1.71
1.21
1.2
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
32
223
1.47
1.20
1.6
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
274
1.42
1.20
1.8
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
190
1.51
1.19
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
26
2.33
1.19
1.0
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
14
79
1.80
1.18
2.9
2.1
ug/l
224.3
253.8
0.11
14
72
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
57
1.95
1.18
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
20
2.52
1.15
2.6
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
38
279
1.40
1.10
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
29
203
1.46
1.08
2.9
3.3
g/l
66.6
67.0
0.09
23
190
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
74
1.78
1.08
1.4
1.3
ug/g
308.4
346.7
—
8
39
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
22
2.29
1.03
1.2
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
83
1.71
1.02
1.6
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
906
1.23
1.02
3.1
4.0
mg/mmol
1.8
8.0
4.98
54
559
(3027945) Reticulocytes/100 erythrocytes in Blood
38
284
1.37
1.01
4.2
3.2
%
2.0
1.8
0.62
38
255
(3020891) Body temperature
15
92
1.65
0.98
4.5
3.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
23
2.19
0.98
1.4
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
23
157
1.49
0.98
6.3
3.0
g/l
121.0
128.9
0.86
23
151
(40768441) Liver Pathology biopsy report
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
85
1.67
0.95
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
93
1.64
0.95
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
134
1.52
0.93
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
28
2.16
0.92
1.3
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
16
102
1.59
0.91
4.4
4.5
%
1.1
0.9
1.68
16
97
(3011288) Drugs identified in Urine by Screen method
15
94
1.62
0.91
1.7
3.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
63
1.77
0.91
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
75
627
1.24
0.89
1.6
1.7
pmol/l
472.6
434.2
0.68
66
518
(3021589) Normoblasts [#/volume] in Blood
170
1540
1.17
0.86
8.1
8.1
e9/l
0.0
0.0
0.76
140
1260
(4306422)
10
57
1.77
0.84
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
32
1.89
0.82
1.3
1.7
g/l
0.9
1.0
—
6
32
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
47
1.72
0.81
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
134
1492
0.85
0.81
2.4
2.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
57
470
1.25
0.78
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
59
1.71
0.76
3.3
3.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
91
1.56
0.76
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
141
1.44
0.76
1.5
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
141
1.44
0.76
1.5
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
53
1.71
0.76
1.3
2.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
51
417
1.25
0.75
1.7
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
24
2.10
0.74
1.6
3.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
142
1.43
0.73
1.5
1.9
—
—
—
0
0
(4268621)
7
40
1.76
0.71
2.0
2.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
57
1.59
0.71
1.2
2.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
320
1.28
0.71
3.4
4.6
ug/l
2.8
9.0
2.39
31
251
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
44
1.60
0.65
1.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
127
0.62
0.65
1.6
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
129
1.41
0.64
1.4
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
81
709
1.18
0.62
4.0
3.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
255
0.73
0.62
1.6
1.7
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
21
0.00
0.60
0.0
1.6
—
5.9
—
0
21
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
140
1.37
0.59
2.7
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
54
1.49
0.57
1.0
1.0
—
—
—
0
0
(4035726)
25
318
0.77
0.57
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
115
1.41
0.57
1.5
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
141
1.36
0.57
1.5
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
11
73
1.52
0.56
6.7
5.4
mmol/l
1.3
1.3
0.04
11
68
(3041096) Erythrocytes [Presence] in Urine by Automated
103
927
1.15
0.56
3.4
2.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
37
1.63
0.55
1.0
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
32
258
1.26
0.55
5.8
4.1
%
1.0
1.2
—
7
72
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
102
918
1.15
0.55
1.9
1.6
mmol/l
1.4
1.4
0.09
91
767
(3052851) Hemolysis interference index of Serum or Plasma
14
99
1.43
0.54
3.6
3.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
435
0.81
0.54
4.8
3.8
%
37.0
32.4
1.37
25
284
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
74
1.50
0.54
1.5
1.2
—
—
—
0
0
(3000492) Spirometry study
41
343
1.22
0.52
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
224
1.27
0.52
3.3
2.9
e9/l
3.5
4.0
0.71
21
181
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
40
1.51
0.52
2.0
2.0
%
13.2
13.2
—
6
40
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
40
1.51
0.52
1.3
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
65
1.39
0.51
1.2
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
65
1.39
0.51
1.8
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
14
101
1.40
0.50
2.6
3.2
g/l
0.5
0.2
—
5
36
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
118
0.67
0.46
1.5
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
49
1.44
0.46
1.0
1.5
—
—
—
0
0
(3012544) pH of Venous blood
30
247
1.23
0.45
6.4
3.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
29
238
1.23
0.45
6.1
3.3
mmol/l
1.4
1.6
0.16
24
188
(3025159) Blasts/100 leukocytes in Blood
28
229
1.24
0.45
6.4
4.3
%
0.0
1.9
—
5
51
(3021879) Hepatitis B virus core Ab [Presence] in Serum
31
257
1.22
0.44
1.5
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
157
1.29
0.44
1.5
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
56
1.44
0.42
1.9
5.3
umol/l
329.9
385.4
—
8
46
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
427
1.17
0.42
3.5
3.6
%
18.3
20.9
0.49
19
181
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
57
1.41
0.42
2.0
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
16
0.00
0.41
0.0
1.1
—
31.8
—
0
16
(3045788) Cell count panel - Pleural fluid
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
34
1.48
0.40
1.6
3.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
18
0.00
0.40
0.0
1.6
—
419.3
—
0
8
(3021440) Promyelocytes/100 leukocytes in Blood
29
242
1.21
0.40
6.2
4.2
%
0.2
0.2
—
6
63
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.3
—
36650.9
—
0
11
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
197
1.23
0.38
1.1
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
36
1.39
0.38
1.8
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.2
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
39
448
0.86
0.37
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
70
1.29
0.37
1.1
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
43
1.40
0.35
1.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
321
1.17
0.35
1.4
1.6
—
—
—
0
0
(4034850)
12
91
1.33
0.34
19.8
5.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
105
977
1.10
0.34
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
100
1.31
0.34
1.2
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
15
118
1.28
0.34
8.0
2.6
%
0.6
0.7
0.82
15
113
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
323
1.16
0.33
2.8
2.5
ug/l
0.8
0.7
0.11
23
192
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
58
526
1.12
0.30
4.7
4.2
ug/l
2.2
2.5
0.16
53
473
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
373
1.14
0.30
1.6
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
62
1.30
0.28
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
62
1.30
0.28
1.5
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
65
1.24
0.27
1.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
72
0.69
0.26
2.0
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
188
1.18
0.26
2.8
1.9
mg/l
2.1
5.7
0.66
14
143
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
2.4
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
77
1.17
0.24
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
24
275
0.87
0.24
3.1
2.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
39
1.29
0.23
2.0
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
88
1.26
0.22
4.5
4.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
25.8
—
0
12
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
0
14
0.00
0.20
0.0
1.4
—
480.6
—
0
7
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
114
0.79
0.20
1.7
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
312
0.89
0.20
3.3
2.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
50
1.20
0.20
2.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
59
1.19
0.18
3.0
1.5
pmol/l
233.6
216.2
—
7
54
(3003740) Influenza virus B Ag [Presence] in Specimen
8
73
1.10
0.16
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
73
1.10
0.16
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
399
0.92
0.15
1.6
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
9
80
1.13
0.15
1.4
1.6
nmol/l
0.6
0.9
—
9
66
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
103
1.17
0.14
2.1
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
99
0.80
0.14
1.1
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
128
0.86
0.13
1.7
1.7
mu/l
328.6
344.5
0.09
11
119
(3023323) Follitropin [Units/volume] in Serum or Plasma
18
201
0.89
0.13
1.2
1.4
iu/l
38.1
30.2
0.35
18
170
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
159
0.88
0.13
1.4
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
127
0.86
0.12
3.6
2.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
168
0.89
0.12
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
270
1.08
0.11
1.3
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
47
1.06
0.09
1.4
1.2
u/l
8.4
26.4
—
5
42
(3004616) Nuclear Ab [Presence] in Serum
5
48
1.04
0.09
1.6
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
63
0.79
0.08
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
88
1.14
0.08
1.2
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
64
1.10
0.08
1.3
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
112
0.89
0.07
3.8
3.1
mmol/l
24.6
25.0
—
10
107
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
82
0.85
0.07
1.1
1.5
—
—
—
0
0
(3019225) pH of Specimen
29
301
0.96
0.04
3.4
4.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
153
1.05
0.01
1.9
1.5
—
—
—
0
0
(3013512) EKG study
94
946
0.99
0.00
4.0
3.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
96
1.04
0.00
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
96
1.04
0.00
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
96
1.04
0.00
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
96
1.04
0.00
1.1
1.4
—
—
—
0
0
(1002224) Polysomnography panel
18
183
0.98
0.00
1.0
1.1
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
57
0.88
0.00
2.2
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
67
0.89
0.00
1.7
2.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.8
—
0.8
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
3.6
—
131.3
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
1.6
1.5
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
101.3
—
0
6
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.2
—
4.5
—
0
5
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
79
0.88
0.00
1.1
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
79
0.88
0.00
1.1
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ILIOTIBBAND and mortality.

Females

Parameter HR [95% CI] p-value
M13_ILIOTIBBAND 0.714 [0.55, 0.93] 0.012
Birth year 0.993 [0.98, 1.0] 0.137

During the follow-up period (1.1.1998 — 31.12.2019), 58 out of 1175 females with M13_ILIOTIBBAND died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_ILIOTIBBAND.

N-year risk Females Males
1 0.072% No data
5 0.395% No data
10 0.934% No data
15 1.941% No data
20 3.434% No data

Relationships between endpoints

↥

Index endpoint: M13_ILIOTIBBAND – Iliotibial band syndrome

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data